CLEARPOINT NEURO INC.
13.42
07-November-24 14:59:54
15 minutes delayed
Stocks
+0.04
+0.30%
Today's range
13.15 - 13.86
ISIN
N/A
Source
NASDAQ
-
12 Dec 2022 08:15:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro to Present at Upcoming Investor Conferences
09 Nov 2022 08:25:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Third Quarter 2022 Results
08 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022
26 Oct 2022 15:05:01 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System
23 Sep 2022 01:45:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer
20 Sep 2022 15:05:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for Software Version 2.1
19 Sep 2022 15:13:08 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Second Quarter 2022 Results
09 Aug 2022 15:15:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model
09 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
08 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022
26 Jul 2022 15:05:01 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces Receipt of MDSAP Certification
02 Jun 2022 15:05:00 By Nasdaq GlobeNewswire
-
20 May 2022 08:29:34 By Nasdaq GlobeNewswire
-
13 May 2022 08:25:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports First Quarter 2022 Results
11 May 2022 15:05:00 By Nasdaq GlobeNewswire
-
ClearPoint Neuro and Higgs Boson Health Announce Collaboration
03 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1
28 Apr 2022 15:05:01 By Nasdaq GlobeNewswire
-
27 Apr 2022 15:05:00 By Nasdaq GlobeNewswire